Literature DB >> 6614170

Renal nerves in renal adaptation to dietary sodium restriction.

G F DiBona, L L Sawin.   

Abstract

To assess the physiologic importance of the renal nerves in the renal mechanisms for the maintenance of body sodium balance, renal adaptation to normal and low sodium diet was evaluated in conscious Sprague-Dawley male rats before and 8 days after recovery from bilateral surgical-pharmacological renal denervation. Renal denervation was confirmed in every rat at the end of the study by absence of renal vasoconstriction to splanchnic nerve stimulation and loss of renal tissue norepinephrine content. Daily sodium balance, defined as the difference between dietary sodium intake and urinary sodium excretion, was positive with the normal sodium diet before and after bilateral renal denervation. Prior to bilateral renal denervation, changing to the low sodium diet was associated with a diminishingly negative sodium balance for 3 days that became progressively positive thereafter. After bilateral renal denervation, changing to the low sodium diet was associated with a continuous and progressively negative sodium balance. We conclude that intact renal innervation is required for normal renal sodium conservation and maintenance of body sodium balance during dietary sodium restriction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614170     DOI: 10.1152/ajprenal.1983.245.3.F322

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

1.  Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Authors:  Steven D Crowley; Susan B Gurley; Michael I Oliverio; A Kathy Pazmino; Robert Griffiths; Patrick J Flannery; Robert F Spurney; Hyung-Suk Kim; Oliver Smithies; Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

2.  Autonomic renal denervation ameliorates experimental glomerulonephritis.

Authors:  Roland Veelken; Eva-Maria Vogel; Karl Hilgers; Kerstin Amann; Andrea Hartner; Gabriele Sass; Winfried Neuhuber; Gisa Tiegs
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

3.  The cardiovascular, endocrine and renal response of tetraplegic and paraplegic subjects to dietary sodium restriction.

Authors:  M Sutters; C Wakefield; K O'Neil; M Appleyard; H Frankel; C J Mathias; W S Peart
Journal:  J Physiol       Date:  1992-11       Impact factor: 5.182

4.  Renal sympathetic denervation in resistant hypertension.

Authors:  Mário Santos; Henrique Carvalho
Journal:  World J Cardiol       Date:  2013-04-26

5.  Lack of renal dopamine D5 receptors promotes hypertension.

Authors:  Laureano Asico; Xiaojie Zhang; Jifu Jiang; David Cabrera; Crisanto S Escano; David R Sibley; Xiaoyan Wang; Yu Yang; Roslyn Mannon; John E Jones; Ines Armando; Pedro A Jose
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

6.  Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion.

Authors:  V Kon; A Yared; I Ichikawa
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

7.  Management of Resistant Hypertension: Do Not Give Up on Medication.

Authors:  Eric Judd; David A Calhoun
Journal:  Nephrol Self Assess Program       Date:  2014-03

8.  Natriuretic and water diuretic effects of guanabenz, a central alpha-2 agonist.

Authors:  M Goldberg; M Gehr; E P MacCarthy
Journal:  Trans Am Clin Climatol Assoc       Date:  1984

9.  Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.

Authors:  T Tomiyama; T Baba; S Murabayashi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 10.  Resistant hypertension in diabetes mellitus.

Authors:  George Bayliss; Larry A Weinrauch; John A D'Elia
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.